US2014296340A1PendingUtilityA1

Combination/association of adapalene and benxoyl peroxide for treating acne lesions

Assignee: GALDERMA RESERCH & DEVPriority: Jul 13, 2006Filed: Jun 11, 2014Published: Oct 2, 2014
Est. expiryJul 13, 2026(expired)· nominal 20-yr term from priority
A61P 43/00A61P 29/00A61P 17/00A61P 17/10A61K 47/20A61K 47/32A61K 9/0014A61K 47/10A61K 47/26A61K 31/327A61K 9/06A61K 47/18A61K 31/192
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A regimen for the therapeutic treatment of acne lesions, the regimen comprising topically applying to the skin of a subject in need of said treatment, as active ingredients, 0.1% to 0.3% adapalene and 2.5% benzoyl peroxide, combined at fixed doses in a single formula that delivers said active ingredients together synergistically to achieve, in a group of such subjects, a degree of success of at least about 20%, wherein said single formula is applied once daily for a period of 12 weeks. 
     
     
         2 - 10 . (canceled)

Join the waitlist — get patent alerts

Track US2014296340A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.